Bruker's Revenues Jump 27 Percent in Q4 as Service and Product Sales Up | GenomeWeb
NEW YORK (GenomeWeb News) — Bruker BioSciences today said fourth-quarter revenues increased 27 percent as R&D spending rose 23 percent and profit nearly doubled.
 
Total receipts for the three months ended Dec. 31, 2006, increased to $135.6 million from $106.7 million year over year.
 
Product revenue increased 25 percent to $120.4 million; service revenue increased 45 percent to $15 million; and “other” revenue decreased 48 percent to $146,000.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.